Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode
Chen Hu(Shanxi University of Finance and Economics), Qingsong Liu(Medical College of Wisconsin)
Cited by 22
Related Papers
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma
|Cancer Research|2013|169
HDAC2 Selectively Regulates FOXO3a-Mediated Gene Transcription during Oxidative Stress-Induced Neuronal Cell Death
|Journal of Neuroscience|2015|112
Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition
|Nature Communications|2019|68